ORIC Pharmaceuticals, Inc.
ORIC Pharmaceuticals, Inc. scores highest on Nitro (84) and lowest on Price (20). Its PosiPenta is 48.98 out of 100, around the middle of similar companies.
On the Penta Grid this week, ORIC Pharmaceuticals, Inc. is Grid #301 of 837 in the Healthcare sector in United States, and Grid #1,995 of 4,000 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| ORIC Pharmaceuticals, Inc. | 48.98 | 20 | 29 | 84 | 63 | 49 |
| Nutex Health Inc. | 63.91 | 63 | 57 | 84 | 61 | 54 |
| Freenome, Inc. | 49.94 | 0 | 24 | 60 | 93 | 72 |
| Inhibrx Biosciences, Inc. | 26.33 | 0 | 16 | 64 | 2 | 50 |
| Eton Pharmaceuticals, Inc. | 58.40 | 5 | 88 | 81 | 61 | 56 |
| Tyra Biosciences, Inc. | 40.29 | 18 | 23 | 44 | 61 | 54 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | -9.36 |
| P/B ratio | 3.36 |
EEarnings
| Trailing EPS | ₹-125.02 |
| Forward EPS | ₹-158.48 |
NNitro
| Price | 1169.73 |
| 52-week high | 1390.42 |
| 52-week low | 684.79 |
| Fall from 52-week high | 15.9% |
TTorque
| Return on equity (ROE) | -39.80% |
| Debt-to-equity | 0.02 |
AAnchor
| Beta (price swings) | 0.98 |
| Market cap | ₹12,124 Cr |
| Insider holding | 1.59% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is ORIC Pharmaceuticals, Inc.'s PosiPenta score?
ORIC Pharmaceuticals, Inc.'s PosiPenta is 48.98 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does ORIC Pharmaceuticals, Inc. stand on the Penta Grid?
On the Penta Grid this week, ORIC Pharmaceuticals, Inc. is Grid #301 of 837 in the Healthcare sector in United States, and Grid #1,995 of 4,000 in United States.
Which PosiPenta pillar is strongest for ORIC Pharmaceuticals, Inc.?
Nitro (momentum), with a score of 84 out of 100: much better than most similar companies.
Which PosiPenta pillar is weakest for ORIC Pharmaceuticals, Inc.?
Price (valuation), with a score of 20 out of 100: much weaker than most similar companies.
Has ORIC Pharmaceuticals, Inc.'s PosiPenta changed since last week?
Yes, it rose 3.62 points, from 45.36 to 48.98.
PositoAI is for research and education only and is not investment advice.